Home / Health / Your Zip Code Could Be Your Health Sentence
Your Zip Code Could Be Your Health Sentence
24 Mar
Summary
- Clinical trial access is heavily influenced by patient location.
- Massachusetts leads in clinical trial access per capita.
- States with low investment lag in trial availability and health.
Patient access to life-saving clinical trials is largely determined by their geographic location within the United States. States with strong medical research infrastructure, such as Massachusetts, California, and New York, offer greater opportunities for trial participation.
Massachusetts ranks highest due to leading research institutions and a high volume of active trials per capita. California and Texas, despite large populations, show significant disparities in per-capita access, with urban areas having more options than rural regions.
Conversely, states like Mississippi, Arkansas, Wyoming, and Alaska exhibit the lowest access scores. These regions often suffer from underinvestment in healthcare and medical research infrastructure, leading to fewer trials and poorer health outcomes for residents.
Cancer research dominates current clinical trials, with a significant portion focused on oncology, often concentrated in states with National Cancer Institute-designated centers. Heart disease, neurological conditions, and rare diseases are also key areas of study.
The disparity highlights a critical need for increased investment in medical research infrastructure nationwide. States that support research hospitals and robust health systems are better positioned to provide timely access to future medical advancements for all their residents.
